Shah资本管理公司强调,针对新冠与流感的联合疫苗,其关键性的第三阶段临床试验必须立即启动。可行的路径包括通过赛诺菲进行合作,或由诺瓦瓦克斯医药自身主导并寻求创新性的合作伙伴关系。该公司认为,此举对于推进该重要疫苗的研发进程至关重要。
Shah资本管理公司强调,针对新冠与流感的联合疫苗,其关键性的第三阶段临床试验必须立即启动。可行的路径包括通过赛诺菲进行合作,或由诺瓦瓦克斯医药自身主导并寻求创新性的合作伙伴关系。该公司认为,此举对于推进该重要疫苗的研发进程至关重要。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.